Category: Forbes

At-Home Brain Stimulation — What Could Possibly Go Wrong?

There are nearly a dozen neurostimulation devices on the market that claim to improve cognitive function by allowing you to zap your brain with a small electrical current. But just because you can now do this at home doesn’t mean it’s a good idea.

Hemophilia, The Musical? It’s Funded By Biotech BioMarin

Rare disease drug company BioMarin put on a show called ‘Hemophilia: The Musical’ performed by teenagers affected by blood disorders.

The Emergency Department Is Healthcare’s One-Night Stand. Are We Ready To Address It?

For many low-income healthcare consumers, situational care is preferable. Here’s why.

Move From Fee-For-Service Medicine Hits Hospital Profits Again

Fitch Ratings says “acute care operating profitability” is set to deteriorate for a third consecutive year for nonprofit hospitals and health systems.

A Spine-Surgery Robot Turned This Entrepreneur Into A Billionaire. But How Well Does His Robot Work?

David C. Paul is riding high on a million-dollar robot designed to make spinal surgeons more accurate. But how effective is it?

The Amazing Ways Artificial Intelligence Is Transforming Genomics and Gene Editing

It is predicted that artificial intelligence (AI) will transform many aspects of our life including healthcare and genomics. AI and machine learning have helped us to understand the genome of organisms and will potentially change the way we treat disea…

FDA Ban On E-Cigarette Flavors: A Showdown Between Protecting Kids And Reducing Harm

The FDA announced multiple new regulations to reduce youth use of e-cigarettes. But will it reduce teen vaping or make it harder for adults to quit smoking–or both?

Why You Should Care About Big Data This Flu Season

Could Twitter help predict how bad flu season will be? What can walk-in clinics tell us about where the worst of the virus will peak? Let’s take a look at how big data could transform patient diagnosis, vaccine development and epidemic prevention throu…

Lung Cancer Awareness Month: Let’s Clear the Smoke

We’re making great progress. More new therapies have been approved for lung cancer in the last three years than in the previous fifty years. Even so, lung cancer still accounts for almost 30 percent of all cancers combined.

California Clears CVS-Aetna Deal After Concession To ‘Not Increase Premiums’

A California regulator Thursday cleared CVS Health’s acquisition of Aetna, securing a commitment to “not increase premiums as a result of the acquisition.”